Rani Therapeutics Holdings, Inc. Class A Common Stock (NASDAQ: RANI) last traded at $0.880, up 3.41% on the session. The quote above updates while this page is open; the figures below are drawn from Rani Therapeutics Holdings, Inc. Class A Common Stock’s own filings and are restated only when a new one is published.
Rani Therapeutics Holdings, Inc. Class A Common Stock trades on NASDAQ under the ticker RANI. Its market capitalisation is $164.71 million.
Valuation measures for Rani Therapeutics Holdings, Inc. Class A Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $164.71M |
|---|---|
| Enterprise value | $172.70M |
| Price / sales | 33.77 |
| Price / book | 4.20 |
| Beta | 3.25 |
Trailing-twelve-month figures tagged in Rani Therapeutics Holdings, Inc. Class A Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $4.88M |
|---|---|
| Net income (TTM) | -$25.65M |
| EPS (TTM) | -$0.130 |
| Operating margin | -675.80% |
| Return on equity | -65.37% |
| Cash | $4.87M |
Range and volume for RANI over the past 52 weeks.
| 52-week high | $3.87 |
|---|---|
| 52-week low | $0.440 |
| Volume | 691.7K |
| Average volume | 888.8K |
| Previous close | $0.851 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.